Search

Alexander Te Mazo

from San Jose, CA
Age ~85

Alexander Mazo Phones & Addresses

  • 2538 Meridian Ave, San Jose, CA 95124 (408) 448-7446
  • 14 Thackery Ln, Cherry Hill, NJ 08003

Publications

Wikipedia

Alec Mazo

View page

Alec Mazo is a Russian-born American professional ballroom dancer based in San Francisco. He became known for his participation in the American edition of ...

Us Patents

Drug-Induced Epigenetic Remodeling To Prevent Fibrosis

View page
US Patent:
20220401454, Dec 22, 2022
Filed:
Jul 7, 2022
Appl. No.:
17/859082
Inventors:
- Philadelphia PA, US
Alexander Mazo - Cherry Hill NJ, US
Svetlana Petruk - Voorhees NJ, US
A. Sue Menko - Merion Station PA, US
Assignee:
Thomas Jefferson University - Philadelphia PA
International Classification:
A61K 31/55
A61K 9/00
Abstract:
A therapeutic treatment for preventing or reducing the formation of fibrosis comprising administering to a patient a UTX or JMJD3 inhibitor that are effective in preventing or reducing fibrosis in situations wherein access to an injury or dysmorphogenetic tissues before the fibrotic process becomes established in the tissues.

Methods For Enhancing Dna Damage And Apoptosis Of Leukemic Cells

View page
US Patent:
20220354845, Nov 10, 2022
Filed:
Aug 21, 2020
Appl. No.:
17/637004
Inventors:
- Philadelphia PA, US
Alexander Mazo - Cherry Hill NJ, US
Svetlana Petruk - Voorhees NJ, US
Patrizia Porazzi - Philadelphia PA, US
International Classification:
A61K 31/497
A61K 31/7068
A61P 35/02
Abstract:
The present invention relates to methods of treating cancer in a subject in need thereof by treatments which enhance DNA damage and apoptosis of leukemic cells.

Drug-Induced Epigenetic Remodeling To Prevent Fibrosis

View page
US Patent:
20200016166, Jan 16, 2020
Filed:
Sep 25, 2017
Appl. No.:
16/335716
Inventors:
- Philadelphia PA, US
Alexander MAZO - Cherry Hill NJ, US
Svetlana PETRUK - Voorhees NJ, US
Sue A. MENKO - Merion Station PA, US
Assignee:
Thomas Jefferson University - Philadelphia PA
International Classification:
A61K 31/55
A61K 9/00
Abstract:
A therapeutic treatment for preventing or reducing the formation of fibrosis comprising administering to a patient a UTX or JMJD3 inhibitor that are effective in preventing or reducing fibrosis in situations wherein access to an injury or dysmorphogenetic tissues before the fibrotic process becomes established in the tissues.
Alexander Te Mazo from San Jose, CA, age ~85 Get Report